Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03233282
Other study ID # 69HCL16_0661
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 30, 2013
Est. completion date May 31, 2018

Study information

Verified date August 2018
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Identify, characterize and then validate electrophysiological markers linking electrophysiological cerebral activity and performance in cognitive and physical fatigability in humans. To do this, noninvasive explorations of electroencephalography (EEG) and magnetoencephalography (MEG) will be carried out under two conditions of different experiments, the first one that induces a cognitive fatigability and the second one that induces physical fatigability.


Recruitment information / eligibility

Status Completed
Enrollment 169
Est. completion date May 31, 2018
Est. primary completion date May 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria MGPFco group:

- Adult subjects, male or female, right-handed or left-handed, from 18 years up to 70 years;

- Having duly completed the entire confidential medical questionnaire;

- Written consent of free, informed and express participation;

- No hearing problems;

- Having normal or corrected vision;

- Affiliation to a Social Security scheme.

Inclusion Criteria MGPFph group:

- Adult subjects, male or female, right-handed or left-handed, from 18 years up to 35 years;

- Practicing at least five hours of sports per week;

- Presenting a certificate of no contraindication to an exercise test, intense sports practice or an energy sport in competition of the current year;

- Having duly completed the entire confidential medical questionnaire;

- Without cardiovascular or motor disability;

- Without tumoral, inflammatory, cardiac, pulmonary, renal, digestive (malabsorption syndrome) or liver disease;

- Written consent of free, informed and express participation;

- Affiliation to a Social Security scheme.

Exclusion Criteria:

- Pregnant women, nursing mothers or those of childbearing age without contraception

- Persons under guardianship, curatorship or any other administrative or judicial measure of deprivation of liberty or of liberty

- Persons protected by the law

- Persons who have performed a maximum stress test within 15 days of the date of inclusion,

- In the course of drug treatments against indicated for the protocol (treatment for neurological diseases, psychiatric ...).

- Metal implants incompatible with MRI (for the subjects concerned, see appendices)

- Metallic implants incompatible with the MEG (for the subjects concerned, see appendices)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Electroencephalography (EEG) multi-sensor
Electrophysiological measurements of cerebral activity will be performed by multi-sensor electroencephalography (EEG), which is a non-invasive method.
Magnetoencephalography (MEG)
Electrophysiological measurements of brain activity will be performed by magnetoencephalography (MEG) which is a non-invasive method.
Behavioral Measures
The evaluation of cognitive performance will be carried out by means of behavioral measures, push-button type, handling of a mouse or a joystick.
Reaction time measurement
The assessment of cognitive performance will be carried out using standard behavioral measures, such as reaction time measurement.
Assessment of physical performance
The assessment of physical performance will be based both on bioenergetic measurements and on quantitative data collected in continuous and relative to the effort (eg instantaneous pedaling speed).
Electrooculogram (EOG)
In order to extract artifacts and verify the physical performances of the subjects, under the conditions of physical fatigability, peripheral electrophysiological recordings will be necessary and complementary to meet the objectives set in this study.
Electromyogram (EMG)
In order to extract artifacts and verify the physical performances of the subjects, under the conditions of physical fatigability, peripheral electrophysiological recordings will be necessary and complementary to meet the objectives set in this study.
Electrocardiogram with 3 leads
In order to extract artifacts and verify the physical performances of the subjects, under the conditions of physical fatigability, peripheral electrophysiological recordings will be necessary and complementary to meet the objectives set in this study.
Electrodermogram (EDG)
In order to extract artifacts and verify the physical performances of the subjects, under the conditions of physical fatigability, peripheral electrophysiological recordings will be necessary and complementary to meet the objectives set in this study.
Consumption of O2 (VO2)
In order to extract artifacts and verify the physical performances of the subjects, under the conditions of physical fatigability, peripheral electrophysiological recordings will be necessary and complementary to meet the objectives set in this study.
Production of CO2 (VCO2)
In order to extract artifacts and verify the physical performances of the subjects, under the conditions of physical fatigability, peripheral electrophysiological recordings will be necessary and complementary to meet the objectives set in this study.

Locations

Country Name City State
France Hospices Civils de Lyon, HFME Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Identify electrophysiological markers in humans depending on whether the experimental conditions induce cognitive fatigability. The evaluation of cognitive performance will be carried out by means of conventional behavioral measures, of the press-button type, handling of a mouse or of a joystick and measurement of reaction time. 7 hours
Primary Identify electrophysiological markers in humans depending on whether the experimental conditions induce physical fatigability with EEG. Electrophysiological measurements of cerebral activity will be performed by multi-sensor electroencephalography (EEG). 7 hours
Primary Identify electrophysiological markers in humans depending on whether the experimental conditions induce physical fatigability with MEG. Electrophysiological measurements of cerebral activity will be carried out by magnetoencephalography (MEG) 7 hours
Secondary Refine (locate at the level of the cortex), the origin of these physiological markers Several types of recordings, passive and non-invasive, will be realized:
Electrooculogram (EOG);
electromyography (EMG);
electrocardiogram (ECG); Systematically in "physical" experiments and for some "cognitive" experiments.
7 hours
Secondary Distinguish between different time scales of performance Several types of recordings, passive and non-invasive, will be realized:
electrodermogram (EDG);
the consumption of O2 (VO2);
production of CO2 (VCO2). Only and systematically, in "physical" experiments.
7 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1